Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

UT Southwestern recruiting patients for heart-failure device study

19.10.2006
Physicians at UT Southwestern Medical Center are part of a multinational clinical trial evaluating a unique implantable device designed to treat a larger number of patients with heart failure.

UT Southwestern is one of the top enrolling centers of the 50 sites in the United States. The Optimizer System is an implantable pulse generator that delivers electrical impulses to the heart for treatment of moderate to severe heart failure. Unlike other heart-failure devices, the Optimizer works by strengthening the pumping force of the heart. The Optimizer System modulates the strength of the heart's contractions rather than controls its rhythm.

"The Optimizer could benefit up to two-thirds of advanced heart-failure patients who may not qualify for other kinds of therapy," said Dr. Jose Joglar, co-investigator of the study and associate professor of medicine in UT Southwestern's Heart, Lung and Vascular Center.

Heart failure is a disease that afflicts more than five million Americans and an estimated 15 million patients worldwide and is one of the most common causes of hospitalization. In patients with heart failure, the heart muscle itself is too weak or damaged to pump enough blood through the body. Medications such as beta blockers and other device-based therapies are typically used to treat patients with heart failure. But not all patients respond to these initial therapies.

"In spite of the advances made over the last 15 years, heart failure remains a common cause of death or disability," said Dr. Owen Obel, cardiologist and assistant professor of internal medicine. "This novel therapy stimulates the heart as it is beating. This makes each heart beat stronger for the time that the device is activated. It could really improve the quality of life for the many thousands of people worldwide who suffer from severe heart-failure symptoms."

Dr. Obel, who heads the electrophysiology and pacing laboratory at the Dallas Veteran Affairs Medical Center, is co-investigator for the UT Southwestern trial and has implanted the devices in the five patients who were selected to the study group receiving the implant. Three additional patients are due to receive the device soon. The study will continue to enroll participants until the end of the year.

Patients who qualify for the Optimizer System undergo a surgical procedure similar to putting in a pacemaker. Typically, the surgery takes about four to five hours and requires three leads to be implanted into the heart itself.

"We've been enrolling patients for more than a year now and so far our experiences have been good," said Dr. Joglar.

Potential study participants, or those who would like more information, should call 214-590-5015.

The UT Southwestern Heart, Lung and Vascular Center is a collaborative effort between UT Southwestern faculty and community physicians who unite to bring their clinical and surgical expertise to patients needing cardiac, pulmonary or vascular care. Seamless, individualized care is available for adult congenital heart disease, cardiac imaging, cardiovascular and thoracic surgery, electrophysiology, general cardiology, heart failure, heart and lung transplant, interventional cardiology, interventional radiology, lung transplant pulmonology, mechanical circulatory assistance, preventive cardiology, pulmonary hypertension, and vascular and endovascular surgery.

Katherine Morales | EurekAlert!
Further information:
http://www.utsouthwestern.edu

More articles from Studies and Analyses:

nachricht Europe’s Demographic Future. Where the Regions Are Heading after a Decade of Crises
10.08.2017 | Berlin-Institut für Bevölkerung und Entwicklung

nachricht Scientists reveal source of human heartbeat in 3-D
07.08.2017 | University of Manchester

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>